Cite
HARVARD Citation
Lafont, E. et al. (2022). Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19. Journal of antimicrobial chemotherapy. pp. 2688-2692. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lafont, E. et al. (2022). Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19. Journal of antimicrobial chemotherapy. pp. 2688-2692. [Online].